Infree | CAS#85801-02-1 | indomethacin prodrug

MedKoo Cat#: 561583 | Name: Infree

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Infree is a prodrug of indomethacin. It acts as a nonsteroidal anti-inflammatory drug (NSAID) and disease-modifying anti-rheumatic drug (DMARD).

Chemical Structure

Infree

CAS#85801-02-1

Theoretical Analysis

MedKoo Cat#: 561583

Name: Infree

CAS#: 85801-02-1

Chemical Formula: C34H40ClNO4

Exact Mass: 561.2646

Molecular Weight: 562.14

Elemental Analysis: C, 72.65; H, 7.17; Cl, 6.31; N, 2.49; O, 11.38

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Infree; INF; Indomethacin farnesil; Indometacin farnesil;

IUPAC/Chemical Name

3,7,11-Trimethyldodeca-2,6,10-trien-1-yl 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetate

InChi Key

CFIGYZZVJNJVDQ-LMJOQDENSA-N

InChi Code

InChI=1S/C34H40ClNO4/c1-23(2)9-7-10-24(3)11-8-12-25(4)19-20-40-33(37)22-30-26(5)36(32-18-17-29(39-6)21-31(30)32)34(38)27-13-15-28(35)16-14-27/h9,11,13-19,21H,7-8,10,12,20,22H2,1-6H3/b24-11+,25-19+

SMILES Code

O=C(OC/C=C(C)/CC/C=C(C)/CC/C=C(C)/C)CC1=C(C)N(C(C2=CC=C(Cl)C=C2)=O)C3=C1C=C(OC)C=C3

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 562.14 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Ono K, Hashimoto T, Satoh T. Eosinophilic pustular folliculitis clinically presenting as orofacial granuloma: successful treatment with indomethacin, but not ibuprofen. Acta Derm Venereol. 2015 Mar;95(3):361-2. doi: 10.2340/00015555-1926. PubMed PMID: 24979363. 2: Hakozaki M, Kikuchi S, Otani K, Tajino T, Konno S. Pseudogout of the acromioclavicular joint: report of two cases and review of the literature. Mod Rheumatol. 2011 Aug;21(4):440-3. doi: 10.1007/s10165-011-0417-8. Epub 2011 Feb 5. Review. PubMed PMID: 21298395. 3: Satoh K, Takano S, Kobayashi T. Keishikajutsubuto (Guizhi-shu-fu-tang) treatment for refractory accumulation of synovial fluid in a patient with pustulotic arthro-osteitis. Fukushima J Med Sci. 2007 Jun;53(1):33-8. PubMed PMID: 17957964. 4: Fujita Y, Fujii T, Takeda N, Tanaka M, Mimori T. Successful treatment of primary Sjögren's syndrome with chronic natural killer lymphocytosis by high-dose prednisolone and indomethacin farnesil. Intern Med. 2007;46(5):251-4. Epub 2007 Mar 1. PubMed PMID: 17329922. 5: Hirohata S, Yanagida T, Kawai M, Kikuchi H. Inhibition of human B cell activation by a novel nonsteroidal anti-inflammatory drug, indometacin famesil. Immunopharmacology. 1999 Nov;44(3):245-54. PubMed PMID: 10598881. 6: Sekine K, Nakajima Y, Sawamoto S, Yamada K, Nakajima M, Miyasaka T, Arioka H, Nakano J, Yamashita N, Ohta K, Mano K. [Vasculo-Behcet's disease with fatal massive hemoptysis]. Nihon Kokyuki Gakkai Zasshi. 1999 Feb;37(2):135-9. Japanese. PubMed PMID: 10214043. 7: Takayama F, Miyazaki T, Aoyama I, Tsukushi S, Sato M, Yamazaki C, Shimokata K, Niwa T. Involvement of interleukin-8 in dialysis-related arthritis. Kidney Int. 1998 Apr;53(4):1007-13. PubMed PMID: 9551411. 8: Hirohata S, Konuma K, Inoue T, Ito K. Interaction of indometacin farnesil, a new nonsteroidal antiinflammatory drug with peripheral blood mononuclear cells from patients with rheumatoid arthritis. Nihon Rinsho Meneki Gakkai Kaishi. 1996 Apr;19(2):136-44. PubMed PMID: 8705690. 9: Nomura K, Sasaki C, Murai T, Mitsuhashi Y, Sato S. Angiolymphoid hyperplasia with eosinophilia: successful treatment with indomethacin farnesil. Br J Dermatol. 1996 Jan;134(1):189-90. PubMed PMID: 8745919. 10: Arakawa T, Fukuda T, Nakagawa K, Higuchi K, Watanabe T, Tominaga K, Kobayashi K. Ulcerogenicity and effect on inhibition of prostaglandin generation of indometacin farnesil, a prodrug of indomethacin, in rat gastric mucosa: comparison with indomethacin or loxoprofen. Drugs Exp Clin Res. 1995;21(3):85-8. PubMed PMID: 7555616. 11: Mishima M, Kobayashi S, Hashida R, Yuzuriha T, Sato T, Satoh T. Enzymatic hydrolysis of indometacin farnesil, a prodrug of indomethacin, by carboxylesterase in cultured synovial cells. Res Commun Chem Pathol Pharmacol. 1991 May;72(2):183-90. PubMed PMID: 1876749. 12: Kumakura S, Mishima M, Kobayashi S, Shirota H, Abe S, Yamada K, Tsurufuji S. Inhibitory effect of indomethacin farnesil, a novel antiinflammatory prodrug, on carrageenin-induced inflammation in rats. Agents Actions. 1990 Mar;29(3-4):286-91. PubMed PMID: 2339670. 13: Mishima M, Kobayashi S, Abe S, Yamato C. Metabolic fate of indometacin farnesil, a prodrug of indomethacin: characteristic biotransformation of indometacin farnesil in rats. Xenobiotica. 1990 Feb;20(2):135-46. PubMed PMID: 2333710. 14: Hara K, Akiyama Y, Kato Y, Orikasa E, Takahira H, Tajima T. [Influence of indometacin farnesil on blood coagulation. Comparison with indomethacin in normal rats and warfarin induced hypoprothrombinemic rats]. Nihon Yakurigaku Zasshi. 1988 Dec;92(6):365-73. Japanese. PubMed PMID: 3250914.